U.S. market Open. Closes in 30 minutes

MGRM | Monogram Orthopaedics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 3.18 - 3.48
52 Week Range 1.5300 - 4.90
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 283,674
Average Volume 145,666
Shares Outstanding 31,701,933
Market Cap 105,567,437
Sector Healthcare
Industry Medical - Devices
IPO Date 2023-05-18
Valuation
Profitability
Growth
Health
P/E Ratio -16.65
Forward P/E Ratio N/A
EPS -0.20
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 28
Country USA
Website MGRM
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.
MGRM's peers: AXNX, BFLY, MASS, NNOX, SENS
*Chart delayed
Analyzing fundamentals for MGRM we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very strong. For more detailed analysis please see MGRM Fundamentals page.

Watching at MGRM technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on MGRM Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙